~~<i id='07516954A6'><strike id='07516954A6'><tt id='07516954A6'><pre id='07516954A6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：hotspot 2025-09-27 12:22:29 - browse：37754

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Coloradans with cystic fibrosis could lose access to Trikafta

focus

explore

hotspot

knowledge

focus

Howdocancerdrugswork?Whatmakesbiotechstocksgoup?Andwhyareventurecapitalistssooptimistic?Wecoverallth

WSS

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Inside the culture of fear in the White House science office of Eric Lander

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

FAMU bans football players from facility after release of rap video shot in team's locker room

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Sophia Smith scores twice for US in in 3

focus

leisure time

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Travis Kelce and the trap of celebrity vaccine endorsements

Jerome Adams on the need for new antivirals for Covid

Sarepta Duchenne therapy fails to meet primary endpoint in trial

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How neuroscience research could help beat back brain cancer

At least 13 dead in Texas as scorching temps continue

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Malaria cases in Florida and Texas: Here’s what you need to know

All of Us, NIH's precision medicine initiative, gets a big boost

focus

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

The health care issue Democrats can’t solve: hospital reform

Malaysia cuts short music fest after British band slams anti

Sophia Smith scores twice for US in in 3

Malaysia cuts short music fest after British band slams anti

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

explore

hotspot

knowledge

focus